In the ER-positive human breast cancer cells MCF7, siRNA-mediated depletion or inhibition of PARP7 using RBN-2397 promotes their proliferation in vitro and in vivo (Zhang et al, 2020; Rasmussen et al, 2021) (Table 2). Here, TIPARP is linked to breast carcinoma.